SCHEMBL2189767

SCHEMBL2189767

N[C@H]1CCC(=O)N[C@H]1c1ccc(Br)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.43
MDM2 Q00987 1/20 0.43
KDM1A O60341 5/20 0.43
KCNH2 Q12809 2/20 0.43
MAOB P27338 2/20 0.43
RCOR1 Q9UKL0 2/20 0.43
KDM1B Q8NB78 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
ALDH1A1 P00352 2/20 0.42
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
TDP1 Q9NUW8 1/20 0.40
RAB9A P51151 1/20 0.38
CRBN Q96SW2 2/20 0.37
DDB1 Q16531 1/20 0.37
POLB P06746 1/20 0.36
NPC1 O15118 1/20 0.36
GAA P10253 1/20 0.36
IL1RN P18510 1/20 0.36
ERAP2 Q6P179 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2190045 1.00 TP53 (0.43) TP53MDM2KDM1AKCNH2MAOB
SCHEMBL2190043 1.00 TP53 (0.43) TP53MDM2KDM1AKCNH2MAOB
SCHEMBL2189775 1.00 TP53 (0.43) TP53MDM2KDM1AKCNH2MAOB
SCHEMBL2189771 1.00 TP53 (0.43) TP53MDM2KDM1AKCNH2MAOB
SCHEMBL8631315 0.83 TDP1 (0.45) TP53MDM2KDM1ASMN1; SMN2ALDH1A1
SCHEMBL2188994 0.83 TP53 (0.49) TP53MDM2KDM1AKCNH2MAOB
SCHEMBL2188979 0.83 TP53 (0.49) TP53MDM2KDM1AKCNH2MAOB
SCHEMBL2188987 0.83 TP53 (0.49) TP53MDM2KDM1AKCNH2MAOB
SCHEMBL8537684 0.83 TP53 (0.49) TP53MDM2KDM1AKCNH2MAOB
SCHEMBL8537685 0.83 TP53 (0.49) TP53MDM2KDM1AKCNH2MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110172297-A1 Oxopiperdinyl And Pyranyl Sulfonamides and Pharmaceutical Compositions Thereof PFIZER INC 2011-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110172297-A1 Oxopiperdinyl And Pyranyl Sulfonamides and Pharmaceutical Compositions Thereof GRIK5, GABRE, GRIK2 TP53 4131/4885MDM2 4630/4885KDM1A 1525/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.